|
|
CTD3389
|
MEXIROF-500
|
CEFUROXIME AXETIL USP EQ. TO CEFUROXIME
|
SALAMA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2019/4641/1055ER
|
KILMAX 250
|
AMORPHOUS CEFUROXIME AXETIL USP EQ. TO CEFUROXIME
|
UMOJA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2019/4642/1054ER
|
KILMAX 500
|
AMORPHOUS CEFUROXIME AXETIL USP EQ. TO CEFUROXIME
|
UMOJA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
CTD3868
|
MEXIROF 125 MG DRY SYRUP
|
CEFUROXIME AXETIL USP EQ. TO CEFUROXIME
|
SALAMA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
CTD3869
|
MEXIROF 250 MG DRY SYRUP
|
CEFUROXIME AXETIL USP EQ. TO CEFUROXIME
|
SALAMA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD6386/12563
|
FUROXICLAV 156.25 SUSPENSION
|
CEFUROXIME WITH POTASSIUM CLAVULANATE FOR ORAL SUSPENSION (156.25 MG/5 ML): CEFUROXIME AXETIL USP EQ. TO CEFUROXIME AND CLAVULANATE POTASSIUM USP EQ. TO CLAVULANIC ACID
|
PHARMSMART LTD
|
Registered
|
Details →
|